GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EME · Dec 31, 2024

EMCOR Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000105634-25-000015General Corporate
Capex intensity50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.51% · OPTIONAL · VALID

Operating cash generation85thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

9.67% · OPTIONAL · VALID

Revenue growth85thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

15.76% · CORE · VALID

Gross margin95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

18.98% · CORE · VALID

Operating margin95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

9.23% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History41 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.48%
Current
0.51%
Delta
0.04%
Cash Generation Decreased
Previous
14.24%
Current
9.67%
Delta
-4.57%
Growth Increased
Previous
15.26%
Current
15.76%
Delta
0.51%
Margin Decreased
Previous
19.87%
Current
18.98%
Delta
-0.89%
Profitability Decreased
Previous
9.83%
Current
9.23%
Delta
-0.60%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.